Related Experiment Video
Updated: Dec 31, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides
Hikari Boki1, Tomomitsu Miyagaki, Yuki Shono
1Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Abstract:
In many malignancies, dysregulation of the Notch pathways, composed of 4 Notch receptors (Notch1-4) and 5 Notch ligands (Jagged1-2, Delta-like ligand-1, 3-4), is associated with their development. In mycosis fungoides, interaction between Notch1 and Jagged1 is known to activate the Notch pathways and promote the proliferation of tumour cells. However, the involvement of other Notch ligands has not been reported. This study investigated the roles of Delta-like ligand 4 in mycosis fungoides. Delta-like ligand 4 mRNA levels in lesional skin of patients with mycosis fungoides were significantly elevated compared with those of normal controls, and correlated with disease-specific mortality. Immunohistochemical staining demonstrated prominent expression of Delta-like ligand 4 on vascular endothelial cells and tumour cells in mycosis fungoides lesional skin. In addition, Delta-like ligand 4 augmented the proliferation of cutaneous T-cell lym-phoma cell lines. These results suggest that enhanced Delta-like ligand 4 expression may contribute directly to the progression of mycosis fungoides through proliferating tumour cells.
Insights
Delta-like ligand 4 (DLL4) is elevated in mycosis fungoides, promoting tumor cell proliferation and disease progression. This finding highlights DLL4 as a potential therapeutic target for this cutaneous T-cell lymphoma.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Notch pathway dysregulation is implicated in many cancers.
- In mycosis fungoides, Notch1 and Jagged1 interactions promote tumor cell proliferation.
- The role of other Notch ligands in mycosis fungoides remains unexplored.
Purpose of the Study:
- To investigate the role of Delta-like ligand 4 (DLL4) in mycosis fungoides.
- To determine if DLL4 expression correlates with disease severity and patient outcomes.
Main Methods:
- Quantitative analysis of DLL4 mRNA levels in lesional skin of mycosis fungoides patients and healthy controls.
- Immunohistochemical staining to assess DLL4 protein expression in mycosis fungoides lesions.
- In vitro studies using cutaneous T-cell lymphoma cell lines to evaluate DLL4's effect on proliferation.
Main Results:
- DLL4 mRNA levels were significantly higher in mycosis fungoides lesional skin compared to normal controls.
- Elevated DLL4 levels correlated with disease-specific mortality.
- DLL4 was prominently expressed on vascular endothelial cells and tumor cells in mycosis fungoides lesions.
- DLL4 enhanced the proliferation of cutaneous T-cell lymphoma cell lines.
Conclusions:
- Enhanced DLL4 expression is a significant finding in mycosis fungoides.
- DLL4 may directly contribute to mycosis fungoides progression by promoting tumor cell proliferation.
- DLL4 represents a potential therapeutic target for mycosis fungoides.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators

